Taking the Pulse - A Health Care and Life Sciences Podcast

⚕️ “Using generative AI… we can design clinical trials that are going to be a little bit easier… and faster to execute.” 🔊John Van Hoy of PPD, a clinical research subsidiary of Thermo Fisher Scientific, shares how AI improves their clinical trials, including the experiences of both patients and researchers. Learn more on how AI is accelerating and improving drug development on episode 218 at www.thepulsehealthcast.com! #healthcarelaw #healthcarepodcast #lifesciences #ai #clinicaltrials

⚕️Recorded at NC Life Sciences Organization’s Annual Meeting, Heather and Matthew are joined by John Van Hoy, Executive Director of Data Science & Advanced Analytics at PPD, a subsidiary of Thermo Fisher Scientific. 🔊 John is an innovator in advanced analytics for the healthcare and life sciences industries and discusses how PPD is leveraging AI to enhance clinical research. Tune in for an insightful conversation about the benefits and challenges of using AI in drug development at www.thepulsehealthcast.com! #healthcarelaw #healthcarepodcast #lifesciences #clinicalresearch #ai

⚕️ “When I started this job eight years ago… 12,000 North Carolinians got up to go work for a Japanese owned company in North Carolina. That number is now 32,000.” 🔊Maynard Nexsen attorney David Robinson shares the growth of Japan’s investment in North Carolina, including in the life sciences industry. Hear more at www.thepulsehealthcast.com! #healthcarelaw #healthcarepodcast #lifesciences #foreigninvestment

⚕️Recorded at NC Life Sciences Organization’s Annual Meeting, Heather and Lauren welcome David Robinson, an attorney at Maynard Nexsen, who also serves as the Honorary Consul for Japan in North Carolina and Chairman of the NC Consular Corps. 🔊  David joins us to share his unique insights on Japanese companies doing business in North Carolina and trends in international investment in the state's life sciences industry. Tune in to the full episode now at www.thepulsehealthcast.com! #healthcarelaw #healthcarepodcast #lifesciences

⚕️ “So any payment, whether it comes from a manufacturer or a foundation like ours… will count towards that patient’s deductible and out-of-pocket max.” 🔊Melissa Horn, MPA of the Arthritis Foundation shares how the non-profit organization is advocating for insurance companies to count outside payments and financial assistance towards a patient’s deductible or out of pocket costs. Hear more about their successful policy changes in 22 states on the full episode at www.thepulsehealthcast.com! #healthcarelaw #healthcarepodcast #healthcarepolicy

⚕️Recorded at NC Life Sciences Organization’s Annual Meeting, Heather and Lauren welcome Melissa Horn, MPA, the Director of State Legislative Affairs at the Arthritis Foundation, a nonprofit organization dedicated to finding a cure for America’s leading cause of disability. 🔊 A three-time cancer survivor, Melissa shares her passion for patient advocacy and healthcare policy. She discusses issues such as reducing drug prices and securing insurance coverage for biomarker testing, which helps to individualize patient treatment plans and improve outcomes. Hear all of this and much more in episode 216 www.thepulsehealthcast.com! #healthcarepodcast #healthcarelaw #healthcarepolicy #patientadvocacy #lifesciences

⚕️ “Our sources are plants and also fungi and bacteria where we identify bioactives, in contrast to pharma - largely they’re synthetic components…” 🔊 Jan-Willem van Klinken, MD PhD MS FACN shares what makes Brightseed different from regular pharmaceutical companies, starting with their focus on using nature to restore human health. Hear more on episode 215 at www.thepulsehealthcast.com! #healthcarelaw #healthcarepodcast #lifesciences #pharma

⚕️Recorded at NC Life Sciences Organization’s Annual Meeting, Heather and Lauren chat with Jan-Willem van Klinken, MD PhD MS FACN, Senior VP of Brightseed, a biotech company using AI to develop natural, plant-based compounds to improve human health. 🔊 Jan-Willem, an expert in nutritional sciences, shares how Brightseed takes a different approach to the traditional pharmaceutical research and development process by using artificial intelligence and focusing on bioactive compounds to create the future of specialized wellness. Listen now at www.thepulsehealthcast.com! #healthcarelaw #healthcarepodcast #lifesciences #bioactives

⚕️Recorded at NC Life Sciences Organization’s Annual Meeting, Heather and Matthew welcome Edgardo Hernandez, who oversees drug product manufacturing at Eli Lilly and Company, an international pharmaceutical company. 🔊 Ed discusses how Eli Lilly develops vital treatments for cancer, diabetes, and other diseases, as well as the company’s significant expansion into North Carolina and what it means for both the company and the local community. Tune in now at www.thepulsehealthcast.com! #healthcarelaw #healthcarepodcast #lifesciences #pharama

⚕️Recorded at NC Life Sciences Organization’s Annual Meeting, Heather and Matthew welcome Igor J., an entrepreneur, former IBM director, and pioneer of the artificial intelligence industry who has been involved in several transformative inventions such as Alexa, Echo, and Fire TV. 🔊 Igor shares his futuristic insights on how life sciences companies are implementing AI, the positive impacts of AI on jobs and businesses, and much more. Tune in now for an informative episode at www.thepulsehealthcast.com! #healthcarelaw #healthcarepodcast #lifesciences #ai #artificialintelligence